dichloroacetic acid has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, JA; Schofield, RS | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Chien, S; Wheeler, TJ; Wiegand, CB | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
| Go, Y; Jeon, JH; Jeon, YH; Kang, HJ; Kim, DW; Kim, HE; Kim, JE; Kim, MJ; Kim, YH; Lee, CH; Lee, IK; Lee, JM; Min, BK; Oh, CJ; Park, BY; Park, S; Yoo, EK | 1 |
3 review(s) available for dichloroacetic acid and cardiovascular agents
| Article | Year |
|---|---|
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
2 other study(ies) available for dichloroacetic acid and cardiovascular agents
| Article | Year |
|---|---|
Fructose-1,6-bisphosphate enhances hypothermic preservation of cardiac myocytes.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Agents; Cell Death; Dichloroacetic Acid; Fructosediphosphates; Glucose; Hypothermia, Induced; Insulin; Male; Myocytes, Cardiac; Preservation, Biological; Rats; Rats, Sprague-Dawley | 2005 |
Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation.
Topics: Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Atherosclerosis; Cardiovascular Agents; Dichloroacetic Acid; Diet, Western; Dyslipidemias; Energy Metabolism; Enzyme Inhibitors; Fibroblast Growth Factors; Gene Expression Regulation; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Mitochondria; Obesity; Oxygen Consumption; Plaque, Atherosclerotic; PPAR alpha; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Messenger; Signal Transduction; Uncoupling Protein 1 | 2019 |